• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Exchangeability of amino acid residues with similar physicochemical properties in coiled-coil interactions?
  Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Carboxylic acids

Introduction to 3,5-Dimethyladamantane-1-carboxylic acid (CAS No. 14670-94-1)

3,5-Dimethyladamantane-1-carboxylic acid, identified by the Chemical Abstracts Service Number (CAS No.) 14670-94-1, is a structurally intriguing compound belonging to the adamantane family. This tricyclic hydrocarbon derivative features a central adamantane core substituted with two methyl groups at the 3rd and 5th positions, further functionalized with a carboxylic acid moiety at the 1st position. Its unique stereochemistry and electronic properties make it a valuable scaffold in pharmaceutical research, materials science, and organic synthesis.

The adamantane framework, characterized by its rigid, diamond-like structure, imparts exceptional stability and lipophilicity to 3,5-Dimethyladamantane-1-carboxylic acid, making it an attractive candidate for drug design. The presence of the carboxylic acid group enhances its reactivity, enabling further derivatization into esters, amides, or salts, which are common strategies in medicinal chemistry. These modifications can fine-tune physicochemical properties such as solubility, bioavailability, and metabolic stability.

Recent advancements in computational chemistry have highlighted the potential of 3,5-Dimethyladamantane-1-carboxylic acid as a pharmacophore in the development of novel therapeutics. Its rigid scaffold mimics natural product structures and can be engineered to interact with biological targets with high specificity. For instance, studies have demonstrated its utility in designing inhibitors targeting protein-protein interactions (PPIs), which are increasingly recognized as key players in various diseases, including cancer and inflammatory disorders.

In the realm of materials science, 3,5-Dimethyladamantane-1-carboxylic acid has been explored for its role in creating advanced polymers and liquid crystals. The adamantane core contributes to thermal stability and mechanical strength, making it suitable for high-performance materials used in electronics and coatings. Additionally, its ability to form stable inclusion complexes with other molecules has been leveraged in drug delivery systems, where it acts as a carrier for hydrophobic payloads.

The synthesis of 3,5-Dimethyladamantane-1-carboxylic acid typically involves multi-step organic transformations starting from commercially available precursors such as adamantane or its halogenated derivatives. Advances in catalytic methods have enabled more efficient and sustainable routes to this compound. For example, transition-metal-catalyzed cross-coupling reactions have been employed to introduce substituents at specific positions on the adamantane ring with high regioselectivity.

Biologically speaking,3,5-Dimethyladamantane-1-carboxylic acid has garnered attention for its potential as a tool compound in biochemical assays. Its structural similarity to natural adamantanes found in certain organisms allows it to serve as a ligand or competitor in enzyme inhibition studies. Researchers have utilized derivatives of this compound to probe the mechanisms of enzymes involved in metabolic pathways and signal transduction.

One notable application of 3,5-Dimethyladamantane-1-carboxylic acid is in the development of radiolabeled probes for positron emission tomography (PET) imaging. The lipophilic nature of the adamantane core facilitates its incorporation into PET tracers designed for neuroimaging or oncology applications. Such probes offer high-resolution visualization of target tissues without significant nonspecific binding due to their optimized pharmacokinetic profiles.

The versatility of 3,5-Dimethyladamantane-1-carboxylic acid extends to its role as an intermediate in fine chemical synthesis. Its carboxylic acid functionality serves as a versatile handle for introducing diverse functional groups via esterification or amidation reactions. This adaptability has made it a preferred building block for constructing complex molecules with tailored properties for industrial applications.

Future research directions may explore novel derivatives of 3,5-Dimethyladamantane-1-carboxylic acid with enhanced biological activity or improved material properties. Innovations in synthetic methodologies could further streamline its production while reducing environmental impact through greener chemistry approaches. Collaborative efforts between academia and industry are likely to drive new applications across multiple disciplines.

• 27334-43-6(1-tert-butylcyclohexane-1-carboxylic acid)
• 26906-52-5(1-Phenanthrenecarboxylicacid, tetradecahydro-6-(hydroxymethyl)-1,4a-dimethyl-7-(1-methylethyl)-)
• 50599-45-6(1,4-dimethylcyclohexane-1-carboxylic acid)
• 33830-12-5(Adamantane-d15-carboxylic Acid)
• 3021-73-6(4a(2H)-Naphthalenecarboxylicacid, octahydro-, cis-)
• 37845-05-9(3-Ethyladamantane-1-carboxylic acid)
• 30424-54-5([1,1'-Bicyclohexyl]carboxylicacid (8CI,9CI))
• 25800-63-9(1-Phenanthrenecarboxylicacid, tetradecahydro-1,4a-dimethyl-7-(1-methylethyl)-)
• 4355-18-4(1,2-Cyclohexanedicarboxylicacid, 1-(2-carboxyethyl)-)
• 43135-99-5(1,2-Cyclohexanedicarboxylicacid, 1,1'-(2,2-dimethyl-1,3-propanediyl) ester)